Pauline M Maki1, Leah H Rubin2, Victor Valcour2, Eileen Martin2, Howard Crystal2, Mary Young2, Kathleen M Weber2, Jennifer Manly2, Jean Richardson2, Christine Alden2, Kathryn Anastos2. 1. From the Departments of Psychiatry (P.M.M., L.H.R.) and Psychology (P.M.M.), University of Illinois at Chicago; the Department of Neurology (V.V.), University of California, San Francisco; the Department of Psychiatry (E.M.), Rush University Medical Center, Chicago, IL; the Department of Neurology (H.C.), SUNY Downstate Medical Center, New York, NY; Georgetown University School of Medicine (M.Y.), Washington, DC; The Core Center (K.M.W.), Bureau of Health Services of Cook County, Chicago, IL; the Department of Neurology (J.M.), Columbia University Medical Center, New York, NY; the Department of Preventative Medicine (J.R.), University of Southern California, Los Angeles; the Department of Epidemiology (C.A.), Johns Hopkins University School of Public Health, Baltimore, MD; and the Departments of Medicine and Epidemiology & Population Health (K.A.), Albert Einstein College of Medicine, New York, NY. pmaki@psych.uic.edu. 2. From the Departments of Psychiatry (P.M.M., L.H.R.) and Psychology (P.M.M.), University of Illinois at Chicago; the Department of Neurology (V.V.), University of California, San Francisco; the Department of Psychiatry (E.M.), Rush University Medical Center, Chicago, IL; the Department of Neurology (H.C.), SUNY Downstate Medical Center, New York, NY; Georgetown University School of Medicine (M.Y.), Washington, DC; The Core Center (K.M.W.), Bureau of Health Services of Cook County, Chicago, IL; the Department of Neurology (J.M.), Columbia University Medical Center, New York, NY; the Department of Preventative Medicine (J.R.), University of Southern California, Los Angeles; the Department of Epidemiology (C.A.), Johns Hopkins University School of Public Health, Baltimore, MD; and the Departments of Medicine and Epidemiology & Population Health (K.A.), Albert Einstein College of Medicine, New York, NY.
Abstract
OBJECTIVE: In the largest cohort study of neuropsychological outcomes among HIV-infected women to date, we examined the association between HIV status and cognition in relation to other determinants of cognitive function (aim 1) and the pattern and magnitude of impairment across cognitive outcomes (aim 2). METHODS: From 2009 to 2011, 1,521 (1,019 HIV-infected) participants from the Women's Interagency HIV Study (WIHS) completed a comprehensive neuropsychological test battery. We used multivariable regression on raw test scores for the first aim and normative regression-based analyses (t scores) for the second aim. The design was cross-sectional. RESULTS: The effect sizes for HIV status on cognition were very small, accounting for only 0.05 to 0.09 SD units. The effect of HIV status was smaller than that of years of education, age, race, income, and reading level. In adjusted analyses, HIV-infected women performed worse than uninfected women on verbal learning, delayed recall and recognition, and psychomotor speed and attention. The largest deficit was observed in delayed memory. The association of low reading level with cognition was greater in HIV-infected compared to HIV-uninfected women. HIV biomarkers (CD4 count, history of AIDS-defining illness, viral load) were associated with cognitive dysfunction. CONCLUSIONS: The effect of HIV on cognition in women is very small except among women with low reading level or HIV-related comorbidities. Direct comparisons of rates of impairment in well-matched groups of HIV-infected men and women are needed to evaluate possible sex differences in cognition.
OBJECTIVE: In the largest cohort study of neuropsychological outcomes among HIV-infectedwomen to date, we examined the association between HIV status and cognition in relation to other determinants of cognitive function (aim 1) and the pattern and magnitude of impairment across cognitive outcomes (aim 2). METHODS: From 2009 to 2011, 1,521 (1,019 HIV-infected) participants from the Women's Interagency HIV Study (WIHS) completed a comprehensive neuropsychological test battery. We used multivariable regression on raw test scores for the first aim and normative regression-based analyses (t scores) for the second aim. The design was cross-sectional. RESULTS: The effect sizes for HIV status on cognition were very small, accounting for only 0.05 to 0.09 SD units. The effect of HIV status was smaller than that of years of education, age, race, income, and reading level. In adjusted analyses, HIV-infectedwomen performed worse than uninfected women on verbal learning, delayed recall and recognition, and psychomotor speed and attention. The largest deficit was observed in delayed memory. The association of low reading level with cognition was greater in HIV-infected compared to HIV-uninfectedwomen. HIV biomarkers (CD4 count, history of AIDS-defining illness, viral load) were associated with cognitive dysfunction. CONCLUSIONS: The effect of HIV on cognition in women is very small except among women with low reading level or HIV-related comorbidities. Direct comparisons of rates of impairment in well-matched groups of HIV-infectedmen and women are needed to evaluate possible sex differences in cognition.
Authors: Jennifer J Manly; Diane M Jacobs; Pegah Touradji; Scott A Small; Yaakov Stern Journal: J Int Neuropsychol Soc Date: 2002-03 Impact factor: 2.892
Authors: Jennifer J Manly; Clifford Smith; Howard A Crystal; Jean Richardson; Elizabeth T Golub; Ruth Greenblatt; Esther Robison; Eileen M Martin; Mary Young Journal: J Clin Exp Neuropsychol Date: 2011-08-23 Impact factor: 2.475
Authors: Pauline M Maki; Lorraine Dennerstein; Margaret Clark; Janet Guthrie; Pamela LaMontagne; Deanne Fornelli; Deborah Little; Victor W Henderson; Susan M Resnick Journal: Brain Res Date: 2010-11-13 Impact factor: 3.252
Authors: A Antinori; G Arendt; J T Becker; B J Brew; D A Byrd; M Cherner; D B Clifford; P Cinque; L G Epstein; K Goodkin; M Gisslen; I Grant; R K Heaton; J Joseph; K Marder; C M Marra; J C McArthur; M Nunn; R W Price; L Pulliam; K R Robertson; N Sacktor; V Valcour; V E Wojna Journal: Neurology Date: 2007-10-03 Impact factor: 9.910
Authors: N A Hessol; M Schneider; R M Greenblatt; M Bacon; Y Barranday; S Holman; E Robison; C Williams; M Cohen; K Weber Journal: Am J Epidemiol Date: 2001-09-15 Impact factor: 4.897
Authors: Jean L Richardson; Eileen M Martin; Nora Jimenez; Kathleen Danley; Mardge Cohen; Valorie L Carson; Barbara Sinclair; J Meg Racenstein; Robyn A Reed; Alexandra M Levine Journal: J Int Neuropsychol Soc Date: 2002-09 Impact factor: 2.892
Authors: Robert K Heaton; Donald R Franklin; Ronald J Ellis; J Allen McCutchan; Scott L Letendre; Shannon Leblanc; Stephanie H Corkran; Nichole A Duarte; David B Clifford; Steven P Woods; Ann C Collier; Christina M Marra; Susan Morgello; Monica Rivera Mindt; Michael J Taylor; Thomas D Marcotte; J Hampton Atkinson; Tanya Wolfson; Benjamin B Gelman; Justin C McArthur; David M Simpson; Ian Abramson; Anthony Gamst; Christine Fennema-Notestine; Terry L Jernigan; Joseph Wong; Igor Grant Journal: J Neurovirol Date: 2010-12-21 Impact factor: 2.643
Authors: April D Thames; Philip Sayegh; Kevin Terashima; Jessica M Foley; Andrew Cho; Alyssa Arentoft; Charles H Hinkin; Susan Y Bookheimer Journal: Neurobiol Dis Date: 2015-10-17 Impact factor: 5.996
Authors: Erin E Sundermann; Robert K Heaton; Elizabeth Pasipanodya; Raeanne C Moore; Emily W Paolillo; Leah H Rubin; Ronald Ellis; David J Moore Journal: AIDS Date: 2018-11-28 Impact factor: 4.177
Authors: Rosemary Fama; Edith V Sullivan; Stephanie A Sassoon; Adolf Pfefferbaum; Natalie M Zahr Journal: Alcohol Clin Exp Res Date: 2016-10-19 Impact factor: 3.455
Authors: Leah H Rubin; Scott A Langenecker; K Luan Phan; Sheila M Keating; Gretchen N Neigh; Kathleen M Weber; Pauline M Maki Journal: Psychoneuroendocrinology Date: 2020-02-07 Impact factor: 4.905